Julie Brahmer, MD of Johns Hopkins Kimmel Comprehensive Cancer Center gives an overview of her presentation which discussed a five-year follow-up of Lung Cancer patients, who were treated with Nivolumab. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Five-Year Follow-Up of Lung Cancer Patients Treated with Nivolumab
